Clinical trial
Evaluation of the Hematocrit Effect on the Blood Glucose Monitor for Personal Use JT100
NCT05158478 is registered in ClinicalTrials.gov with Institut fur Diabetes Karlsburg GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Hematocrit Effect on the Blood Glucose Monitor for Personal Use JT100
- Lead sponsor
- Institut fur Diabetes Karlsburg GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2022
- Completion date
- March 14, 2022
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.